Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000018.pdf 0001883850-23-000018.xls
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000020.pdf 0001883850-23-000020.xls
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000021.pdf 0001883850-23-000021.xls
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000019.pdf 0001883850-23-000019.xls
Jan 05, 2023	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-23-000023.pdf 0001883850-23-000023.xls
Dec 30, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000143.pdf 0001883850-22-000143.xls
Dec 21, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000141.pdf 0001883850-22-000141.xls
Dec 20, 2022	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-128613.pdf 0001104659-22-128613.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Dec 20, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000132.pdf 0001883850-22-000132.xls
Dec 20, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000131.pdf 0001883850-22-000131.xls

Data provided by Kaleidoscope.

Investors & Media